COVID-19 group N = 20 | Control group N = 20 | P value | |
---|---|---|---|
MNC amplitude (mV) | 8.88 ± 2.60 | 9.04 ± 2.12 | |
Median nerve | 5.12–13.5 | 6.43–17.10 | 0.039* |
MNC latency (ms) | 5.1 ± 1.34 | 3.29 ± 0.64 | |
Median nerve | 2.59–7.45 | 2.16–4.78 | < 0.001* |
MNC velocity (m/s) | 58.06 ± 6.4 | 58.18 ± 7.30 | |
Median nerve | 42.40–69.30 | 45.92–70.9 | 0.220 |
SNC amplitude (mV) | 21.18 ± 8.76 | 21.19 ± 5.94 | |
Median nerve | 11.5–45.4 | 12.45–38 | 0.091 |
SNC latency (ms) | 4.33 ± 0.91 | 3.47 ± 0.72 | |
Median nerve | 3.08–6.20 | 2.76–5.23 | 0.305 |
SNC velocity (m/s) | 51.7 ± 5.62 | 51.99 ± 6.84 | |
Median nerve | 42.9 – 59.24 | 41.29–69.2 | 0.753 |
F wave latency (ms) | 33.03 ± 4.59 | 30.14 ± 6.16 | |
Median nerve | 26.6–39.3 | 24.56–44.56 | 0.389 |
MNC amplitude (mV) | 12.30 ± 2.15 | 12.84 ± 2.70 | |
Post Tibial nerve | 7.39–17.53 | 8.24–19.1 | 0.366 |
MNC latency (ms) | 3.99 ± 0.99 | 3.06 ± 0.61 | |
Post Tibial nerve | 2.25–5.6 | 2.29–4.22 | 0.007* |
MNC velocity (m/s) | 56.6 ± 5.44 | 57.05 ± 5.24 | |
Post Tibial nerve | 49.2–69.1 | 51.2–68.3 | 0.703 |
SNC amplitude (mV) | 28.1 ± 4.44 | 28.25 ± 4.44 | |
Sural nerve | 21.2–35.3 | 21.3–36.2 | 0.956 |
SNC latency (m/s) | 3.81 ± 0.6 | 3.01 ± 0.59 | |
Sural nerve | 2.68–4.70 | 2.11–3.98 | 0.760 |
SNC velocity (m/s) | 56.7 ± 8.25 | 57.15 ± 6.05 | |
Sural nerve | 43.1–76.2 | 47.1–68.4 | 0.281 |
F wave latency (ms) | 52.28 ± 4.95 | 47.25 ± 3.17 | |
Post Tibial nerve | 43.2–61.6 | 42.3–52.1 | 0.002* |